Works by Durrieu, Geneviève


Results: 45
    1
    2
    3
    4
    5

    Tamoxifen and the risk of Parkinsonism: a case/non-case study.

    Published in:
    European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1181, doi. 10.1007/s00228-018-2496-3
    By:
    • Montastruc, François;
    • Khosrow-Khavar, Farzin;
    • de Germay, Sibylle;
    • Renoux, Christel;
    • Rousseau, Vanessa;
    • Durrieu, Geneviève;
    • Montastruc, Marion;
    • Rascol, Olivier;
    • Sommet, Agnès;
    • Lapeyre-Mestre, Maryse;
    • Benevent, Justine;
    • Montastruc, Jean-Louis
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Pharmaceutical Sales Representatives and Patient Safety.

    Published in:
    JGIM: Journal of General Internal Medicine, 2013, v. 28, n. 11, p. 1395, doi. 10.1007/s11606-013-2563-5
    By:
    • Mintzes, Barbara;
    • Lexchin, Joel;
    • Wilkes, Michael;
    • Beaulieu, Marie-Dominique;
    • Reynolds, Ellen;
    • Sutherland, Jason;
    • Durrieu, Geneviève
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2013, v. 22, n. 9, p. 952, doi. 10.1002/pds.3471
    By:
    • Laroche, Marie‐Laure;
    • Perault‐Pochat, Marie‐Christine;
    • Ingrand, Isabelle;
    • Merle, Louis;
    • Kreft‐Jais, Carmen;
    • Castot‐Villepelet, Anne;
    • Durrieu, Geneviève;
    • Gras, Valérie;
    • Guy, Claire;
    • Jean‐Pastor, Marie‐Josèphe;
    • Jonville‐Béra, Annie‐Pierre;
    • Merlet‐Chicoine, Isabelle;
    • Miremont‐Salamé, Ghada;
    • Nourhashemi, Fati;
    • Charmes, Jean‐Pierre
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

    Published in:
    2012
    By:
    • Durrieu G;
    • Palmaro A;
    • Pourcel L;
    • Caillet C;
    • Faucher A;
    • Jacquet A;
    • Ouaret S;
    • Perault-Pochat MC;
    • Kreft-Jais C;
    • Castot A;
    • Lapeyre-Mestre M;
    • Montastruc JL;
    • Durrieu, Geneviève;
    • Palmaro, Aurore;
    • Pourcel, Laure;
    • Caillet, Céline;
    • Faucher, Angeline;
    • Jacquet, Alexis;
    • Ouaret, Shéhérazade;
    • Perault-Pochat, Marie Christine
    Publication type:
    journal article
    32

    EEG, MAO-A inhibition, pharmacokinetics and safety of befloxatone in the elderly.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 1997, v. 12, n. 6, p. 557, doi. 10.1002/(SICI)1099-1077(199711/12)12:6<557::AID-HUP923>3.0.CO;2-P
    By:
    • Patat, Alain;
    • Dubruc, Catherine;
    • Deschamp, Claire;
    • Durrieu, Geneviève;
    • Trocherie, Suzanne;
    • Cimarosti, Isabelle;
    • Allain, Hervé;
    • Rosenzweig, Pierre;
    • Gandon, Jean-Marc
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Atropinic (anticholinergic) burden in antipsychotic‐treated patients.

    Published in:
    Fundamental & Clinical Pharmacology, 2018, v. 32, n. 1, p. 114, doi. 10.1111/fcp.12321
    By:
    • Montastruc, François;
    • Benevent, Justine;
    • Touafchia, Anthony;
    • Chebane, Leila;
    • Araujo, Mélanie;
    • Guitton‐Bondon, Emmanuelle;
    • Durrieu, Geneviève;
    • Arbus, Christophe;
    • Schmitt, Laurent;
    • Begaud, Bernard;
    • Montastruc, Jean‐Louis
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45